Summary for Clinicians: Clinical Practice Guideline for the Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplant
Hematopoietic stem cell transplant (HSCT) is an established treatment for many pediatric malignant and nonmalignant conditions with increasing rates each year worldwide. Although overall survival after HSCT has improved, pulmonary complications are the leading cause of nonrelapse mortality.
Category
  • General Interest
  • Pulmonary
Format
  • Journal
Credits
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Participation
Cost $25.00